Perspective Therapeutics, Inc. (CATX) Reports In-Line Q2 EPS

Perspective Therapeutics, Inc. (NYSE: CATX) reported Q2 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $290 thousand versus the consensus estimate of $185.86 thousand.

For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Delta Air Lines stock climbs on earnings beat and strong guidance
• Popular stocks with increasing option volume: MU SOFI PLTR INTC NFLX MSTR SPCX HOOD ORCL